Shingles vaccination can cut older adults’ risk of developing dementia, study says
- A new study found shingles vaccination cut older adults' risk of developing dementia over the next seven years by 20%.
- The study tracked people in Wales who were around 80 when receiving the world's first-generation shingles vaccine over a decade ago.
- Now, Americans 50 and older are urged to get a newer vaccine that's proven more effective against shingles than its predecessor.
251 Articles
251 Articles
Getting vaccinated against 'shingles fire' could protect against senile dementia
This is suggested by a study by Stanford University (California) on 280,000 elderly people in Wales, born between 1925 and 1942. It has not yet been possible to establish whether the link is causal
Study: Shingles vaccine could reduce risk of dementia
By Jack Phillips Contributing Writer A new study finds that the shingles vaccine sometimes offered to older adults has been associated with a decrease in the development of dementia later on. Published in the Nature journal on Wednesday, the study found that older adults who received the zoster vaccine, also known as the shingles vaccine, were 20% less likely to develop dementia over the next seven years after receiving the shot, as compared w…
Shingles Shot Slashes Dementia Risk by 20% in Landmark Stanford Study
A rare policy quirk in Wales offered scientists an accidental natural experiment—and what they found could reshape how we prevent dementia. Researchers discovered that people eligible for the shingles vaccine were 20% less likely to develop dementia years later. It’s the clearest link yet between a common virus and cognitive decline, and it might mean [...]
Coverage Details
Bias Distribution
- 64% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage